These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21498513)

  • 41. Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity.
    Fatouros C; Pir GJ; Biernat J; Koushika SP; Mandelkow E; Mandelkow EM; Schmidt E; Baumeister R
    Hum Mol Genet; 2012 Aug; 21(16):3587-603. PubMed ID: 22611162
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Understanding the kinetic roles of the inducer heparin and of rod-like protofibrils during amyloid fibril formation by Tau protein.
    Ramachandran G; Udgaonkar JB
    J Biol Chem; 2011 Nov; 286(45):38948-59. PubMed ID: 21931162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resonance Raman spectroscopic measurements delineate the structural changes that occur during tau fibril formation.
    Ramachandran G; Milán-Garcés EA; Udgaonkar JB; Puranik M
    Biochemistry; 2014 Oct; 53(41):6550-65. PubMed ID: 25284680
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reversibility of Tau-related cognitive defects in a regulatable FTD mouse model.
    Sydow A; Van der Jeugd A; Zheng F; Ahmed T; Balschun D; Petrova O; Drexler D; Zhou L; Rune G; Mandelkow E; D'Hooge R; Alzheimer C; Mandelkow EM
    J Mol Neurosci; 2011 Nov; 45(3):432-7. PubMed ID: 21822709
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis.
    von Bergen M; Barghorn S; Müller SA; Pickhardt M; Biernat J; Mandelkow EM; Davies P; Aebi U; Mandelkow E
    Biochemistry; 2006 May; 45(20):6446-57. PubMed ID: 16700555
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FRET-based Tau seeding assay does not represent prion-like templated assembly of Tau filaments.
    Kaniyappan S; Tepper K; Biernat J; Chandupatla RR; Hübschmann S; Irsen S; Bicher S; Klatt C; Mandelkow EM; Mandelkow E
    Mol Neurodegener; 2020 Jul; 15(1):39. PubMed ID: 32677995
    [TBL] [Abstract][Full Text] [Related]  

  • 47. O-GlcNAc modification of tau directly inhibits its aggregation without perturbing the conformational properties of tau monomers.
    Yuzwa SA; Cheung AH; Okon M; McIntosh LP; Vocadlo DJ
    J Mol Biol; 2014 Apr; 426(8):1736-52. PubMed ID: 24444746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology.
    Esteras N; Abramov AY
    Cells; 2020 Sep; 9(9):. PubMed ID: 32967303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
    Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
    J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro.
    Aillaud I; Kaniyappan S; Chandupatla RR; Ramirez LM; Alkhashrom S; Eichler J; Horn AHC; Zweckstetter M; Mandelkow E; Sticht H; Funke SA
    Alzheimers Res Ther; 2022 Jan; 14(1):15. PubMed ID: 35063014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Folding of the repeat domain of tau upon binding to lipid surfaces.
    Barré P; Eliezer D
    J Mol Biol; 2006 Sep; 362(2):312-26. PubMed ID: 16908029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A mechanistic model of tau amyloid aggregation based on direct observation of oligomers.
    Shammas SL; Garcia GA; Kumar S; Kjaergaard M; Horrocks MH; Shivji N; Mandelkow E; Knowles TP; Mandelkow E; Klenerman D
    Nat Commun; 2015 Apr; 6():7025. PubMed ID: 25926130
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.
    Patterson KR; Remmers C; Fu Y; Brooker S; Kanaan NM; Vana L; Ward S; Reyes JF; Philibert K; Glucksman MJ; Binder LI
    J Biol Chem; 2011 Jul; 286(26):23063-76. PubMed ID: 21550980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of an aggregation-prone structure of tau.
    Elbaum-Garfinkle S; Rhoades E
    J Am Chem Soc; 2012 Oct; 134(40):16607-13. PubMed ID: 22998648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.
    Ji M; Xie XX; Liu DQ; Yu XL; Zhang Y; Zhang LX; Wang SW; Huang YR; Liu RT
    Alzheimers Res Ther; 2018 Jun; 10(1):55. PubMed ID: 29914543
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Three- and four-repeat Tau coassemble into heterogeneous filaments: an implication for Alzheimer disease.
    Siddiqua A; Margittai M
    J Biol Chem; 2010 Nov; 285(48):37920-6. PubMed ID: 20921227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structural determinants of Tau aggregation inhibitor potency.
    Schafer KN; Cisek K; Huseby CJ; Chang E; Kuret J
    J Biol Chem; 2013 Nov; 288(45):32599-32611. PubMed ID: 24072703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HspB1 and Hsc70 chaperones engage distinct tau species and have different inhibitory effects on amyloid formation.
    Baughman HER; Clouser AF; Klevit RE; Nath A
    J Biol Chem; 2018 Feb; 293(8):2687-2700. PubMed ID: 29298892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C-H ... π interplay between Ile308 and Tyr310 residues in the third repeat of microtubule binding domain is indispensable for self-assembly of three- and four-repeat tau.
    Sogawa K; Okuda R; In Y; Ishida T; Taniguchi T; Minoura K; Tomoo K
    J Biochem; 2012 Sep; 152(3):221-9. PubMed ID: 22659094
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Triggers of full-length tau aggregation: a role for partially folded intermediates.
    Chirita CN; Congdon EE; Yin H; Kuret J
    Biochemistry; 2005 Apr; 44(15):5862-72. PubMed ID: 15823045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.